We first confirmed expression of the putative novel miR137 targets (KDM2A, KDM5B, KDM7A, CBP, SUZ12, MED1) and the KDM1A and NCoA2 validated miR137 targets in PCa cell lines (Figure 2). The gene discussed is KDM5B; the disease is posterior cortical atrophy.